Evidence map›Paper›PMID 36460803›Full record

ArticleCancer gene therapy2023

Single-cell discovery of the scene and potential immunotherapeutic target in hypopharyngeal tumor environment.

Chen Lin, Yanguo Li, Yidian Chu, Yaqin Lu, Zhengyu Wei, Hongxia Deng, Shanshan Gu, Qi Ding, Zhisen Shen, Qi Liao

Open access · hybridFull text read
In one paragraph

Article in Cancer gene therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chen LinThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China.ORCID 0000-0003-2237-8568
Yanguo LiInstitute of Drug Discovery Technology, Ningbo University, Ningbo, China.
Yidian ChuThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China.
Yaqin LuThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China.
Zhengyu WeiThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China.ORCID 0000-0002-0001-1231
Hongxia DengThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China.
Shanshan GuThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China.
Qi DingThe Ningbo Diagnostic Pathology Center, Ningbo, China.
Zhisen ShenThe Affiliated Lihuili Hospital, Ningbo University, Ningbo, China. szs7216@163.com.ORCID 0000-0001-6660-0488
Qi LiaoSchool of Medicine, Ningbo University, Ningbo, China. liaoqi@nbu.edu.cn.ORCID 0000-0001-6796-104X
Ningbo University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypopharyngeal carcinoma is a cancer with the worst prognosis. We constructed the first single-cell transcriptome map for hypopharyngeal carcinoma and explored its underlying mechanisms. We systematically studied single-cell transcriptome data of 17,599 cells from hypopharyngeal carcinoma and paracancerous tissues. We identified categories of cells by dimensionality reduction and performed further subgroup analysis. Focusing on the potential mechanism in the cellular communication of hypopharyngeal carcinoma, we predicted ligand-receptor interactions and verified them via immunohistochemical and cellular experiments. In total, seven cell types were identified, including epithelial and myeloid cells. Subsequently, subgroup analysis showed significant tumor heterogeneity. Based on the pathological type of squamous cell carcinoma, we focused on intercellular communication between epithelial cells and various cells. We predicted the crosstalk and inferred the regulatory effect of cellular active ligands on the surface receptor of epithelial cells. From the top potential pairs, we focused on the BMPR2 receptor for further research, as it showed significantly higher expression in epithelial cancer tissue than in adjacent tissue. Further bioinformatics analysis, immunohistochemical staining, and cell experiments also confirmed its cancer-promoting effects. Overall, the single-cell perspective revealed complex crosstalk in hypopharyngeal cancer, in which BMPR2 promotes its proliferation and migration, providing a rationale for further study and treatment of this carcinoma.

Indexed as

Carcinoma, Squamous CellHypopharyngeal NeoplasmsBone Morphogenetic Protein Receptors, Type IIGene Expression Regulation, NeoplasticHumansImmunotherapyPrognosisSingle-Cell Gene Expression AnalysisBMPR2 protein, humanBone Morphogenetic Protein Receptors, Type II

Identifiers

PMID36460803
PMCPMC10014576
OpenAlexW4310643044

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read31
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.